← Leaderboards
Paul D Gershon
Texas A&M University Health Science Ctr
$6,073,054
Attributed
$7,838,874
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,838,874 · 10
By mechanism
R01$5,468,443 · 3
S10$1,417,213 · 3
R21$841,649 · 2
P30$111,569 · 2
Top collaborators
- Bert L. Semler5 shared
- Yongsheng Shi5 shared
- Charles G Glabe2 shared
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- David E Dostal$2,264,687
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMass Spectrum AnalysisVirionMolecularBasePeptidesComplexFamilyTransmission ProcessRna VirusesGenesVaccinia VirusVirusStructural ProteinStructureResolutionMessenger RnaCellsPublishingIonsAntiviral AgentsProteomicsFutureData Set
Grant awards (28)
From hybrid to Tribrid: A refurbished Orbitrap Eclipse Tribrid Mass Spectrometer$738,091
S10 · FY2025 · OD · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2025 · AI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2024 · AI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2023 · AI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2022 · AI
Molecular architecture of the Vaccinia virion by structural proteomics$330,730
R01 · FY2022 · GM · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$462,544
R01 · FY2021 · AI
Molecular architecture of the Vaccinia virion by structural proteomics$332,004
R01 · FY2021 · GM · contact PI
Molecular architecture of the Vaccinia virion by structural proteomics$333,207
R01 · FY2020 · GM · contact PI
Molecular architecture of the Vaccinia virion by structural proteomics$332,424
R01 · FY2019 · GM · contact PI
Novel nuclear and intracellular pathology in early AD$186,725
R21 · FY2015 · AG
Novel nuclear and intracellular pathology in early AD$244,541
R21 · FY2014 · AG
The Pox Virion Molecular Interactome$193,125
R21 · FY2014 · AI · contact PI
LTQ Velos Pro mass spectrometer with ETD and other options$374,122
S10 · FY2013 · OD · contact PI
The Pox Virion Molecular Interactome$217,258
R21 · FY2013 · AI · contact PI
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)$47,611
P30 · FY2013 · CA · contact PI
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)$20,689
P30 · FY2011 · CA · contact PI
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)$21,859
P30 · FY2010 · CA · contact PI
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)$21,410
P30 · FY2009 · CA · contact PI
Mechanism of Poly(a) Tail Formation by Vaccinia Virus$260,276
R01 · FY2007 · GM · contact PI
Mechanism of Poly(a) Tail Formation by Vaccinia Virus$268,049
R01 · FY2006 · GM · contact PI
Mechanism of Poly(a) Tail Formation by Vaccinia Virus$274,500
R01 · FY2005 · GM
Mechanism of Poly(a) Tail Formation by Vaccinia Virus$273,000
R01 · FY2004 · GM
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS$248,406
R01 · FY2002 · GM
MALDI TOF MASS SPECTROMETER$305,000
S10 · FY2001 · RR
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS$241,255
R01 · FY2001 · GM
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS$15,000
R01 · FY2001 · GM
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS$234,312
R01 · FY2000 · GM